Dr. Deborah Hemingway is the Founder and Managing Partner of Ecphora Capital, Maryland’s premiere medtech venture capital firm based in Baltimore, Maryland. Under her leadership, Ecphora Capital has deployed $27 million across 15 portfolio companies in the past three years, establishing itself as a key force in early-stage healthcare innovation. The firm holds strategic partnerships with most premier medical research and advanced manufacturing institutions in the DMV.
Over the past 20 years, Dr. Hemingway has founded, funded, and served on the boards of 61 startups, bringing a wealth of expertise in medical device commercialization, strategic growth, and venture investment. Her career reflects a consistent focus on building and scaling transformative technologies at the intersection of science, healthcare, and entrepreneurship.
Dr. Hemingway earned her Ph.D. in Biophysics from the University of Maryland, College Park and is widely recognized for her sharp investment instincts, operational rigor, and commitment to cultivating lasting impact in the medtech space throughout the mid-Atlantic region.